Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1408
| Despition | SH3-Domain GRB2-Like 3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1031 | Recombinant Human CD24 Protein (Fc Tag) (AC1031) | 50 µg | inquiry |
| ACPP-1398 | Rat TIMP1 Protein (AC1398) | 2 µg | inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
| ACPP-1570 | Human Acrp30 Protein, Trimeric (AC1570) | 2 µg | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
| ACPP-1500 | Mouse PEBP1 Protein (AC1500) | 5 µg | inquiry |
| ACPP-1784 | Human GPI Protein (AC1784) | 5 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1487 | Human Pleiotrophin Protein (AC1487) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.